Lactic acidosis in HIV-exposed infants with perinatal exposure to antiretroviral therapy

Ira Shah1

  • 1HIV Clinic, Department of Pediatrics, B. J. Wadia Hospital for Children, Mumbai, India. irashah@pediatriconcall.com

Insights

Perinatal exposure to nucleoside reverse transcriptase inhibitors (NRTI) in infants can lead to symptomatic lactic acidosis (LA). Monitoring for LA symptoms in HIV-exposed infants receiving NRTI is crucial.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Toxicology

Background:

  • Nucleoside reverse transcriptase inhibitors (NRTI) are associated with lactic acidosis (LA) and hepatosteatosis with prolonged use.
  • Symptomatic LA in infants due to perinatal antiretroviral therapy (ART) exposure is rarely reported in developing nations.

Observation:

  • Three cases of infants developing symptomatic lactic acidaemia following perinatal exposure to zidovudine (ZVD) are presented.
  • One HIV-infected infant exposed antenatally and postnatally to ZVD developed liver dysfunction and mental retardation.
  • Two HIV-uninfected infants exposed to ZVD, with or without other ART drugs, presented with LA and metabolic acidosis.

Findings:

  • Perinatal NRTI exposure, including ZVD, can cause symptomatic LA in HIV-exposed infants.
  • The severity of LA varied, with one case presenting as life-threatening metabolic acidosis.

Implications:

  • Healthcare providers should monitor HIV-exposed infants for symptoms of LA, especially those with perinatal NRTI exposure.
  • Early detection and intervention are essential for managing NRTI-induced LA in infants.
  • This highlights a potential risk of ART in developing countries where reporting is scarce.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...